IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cardium Therapeutics Inc

CUSIP: 141916106 | 14 institutional holders

Quarters

Q4 2013Q2 2013Q1 2013Q4 2012Q3 2012
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2013

Vantage Investment Advisors, LLC1,350
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Vantage Investment Advisors, LLC
1,350$10.0%N/AN/AState College, PA2014-02-12